Literature DB >> 3860166

Controlled release of drug model from N-(2-hydroxypropyl)-methacrylamide copolymers.

J Kopecek, P Rejmanová, R Duncan, J B Lloyd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3860166     DOI： 10.1111/j.1749-6632.1985.tb18393.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

Review 1.  Polymer-drug conjugates: origins, progress to date and future directions.

Authors:  Jindřich Kopeček
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

2.  Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.

Authors:  R Duncan; P Kopecková; J Strohalm; I C Hume; J B Lloyd; J Kopecek
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

Review 3.  Nanopharmaceuticals (part 2): products in the pipeline.

Authors:  Volkmar Weissig; Diana Guzman-Villanueva
Journal:  Int J Nanomedicine       Date:  2015-02-11

4.  Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.

Authors:  R Duncan; P Kopecková-Rejmanová; J Strohalm; I Hume; H C Cable; J Pohl; J B Lloyd; J Kopecek
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.